Gastric Atrophy and Intestinal Metaplasia before and after Helicobacter pylori Eradication: A Meta-Analysis
- 1 February 2011
- journal article
- research article
- Published by S. Karger AG in Digestion
- Vol. 83 (4), 253-260
- https://doi.org/10.1159/000280318
Abstract
Whether gastric atrophy (GA) and intestinal metaplasia (IM) are reversible after the eradication of Helicobacter pylori remains controversial. The purpose of this meta-analysis was to systematically review histological alterations in GA and IM by comparing histological scores before and after H. pylori eradication. English-language articles in the medical literature containing information about the association between infection with H. pylori and gastric premalignant lesions (i.e. GA and IM) were identified by searching the Medline, PubMed, and EMBASE databases with suitable key words up to December 2009. Review Manager 4.2.8 was used for the meta-analysis. Twelve studies containing a total of 2,658 patients were included in the first meta-analysis. Before treatment, 2,648 patients had antrum GA, 2,401 patients had corpus GA, 2,582 patients had antrum IM, and 2,460 patients had corpus IM. Comparing the histological alterations before and after H. pylori eradication, the pooled weighted mean difference (WMD) with 95% CI for antral GA was 0.12 (0.00-0.23), p = 0.06. For corpus GA, the pooled WMD was 0.32 (0.09-0.54), p = 0.006. For antral IM, the pooled WMD was 0.02 (-0.12-0.16), p = 0.76, and for corpus IM, the pooled WMD was -0.02 (-0.05-0.02), p = 0.42. Our study shows that eradication of H. pylori results in significant improvement in GA in the corpus but not in the antrum; it also does not improve gastric mucous IM. Consequently, all patients with GA in the corpus should be tested for H. pylori infection, and eradication therapy should be prescribed for H. pylori-positive patients in those with GA in corpus.Keywords
This publication has 30 references indexed in Scilit:
- Rejuvenation of atrophic gastritis in the elderlyJournal of Gastroenterology and Hepatology, 2010
- Randomized Double-Blind Factorial Trial of Three Treatments To Reduce the Prevalence of Precancerous Gastric LesionsJNCI Journal of the National Cancer Institute, 2006
- Long term follow up of patients treated for Helicobacter pylori infectionGut, 2005
- Long‐term follow‐up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 2005
- Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradicationGut, 2004
- Five‐year follow‐up study on histological and endoscopic alterations in the gastric mucosa after Helicobacter pylori eradicationDigestive Endoscopy, 2004
- Is Helicobacter pylori Infection a Necessary Condition for Noncardia Gastric Cancer?American Journal of Epidemiology, 2004
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer DiseaseJAMA, 1994
- The Sydney System: Histological divisionJournal of Gastroenterology and Hepatology, 1991